Oridonin acts as a novel senolytic by targeting glutathione S-transferases to activate the ROS-p38 signaling axis in senescent cells
Authors:
- 19 October 2022
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 58 (95) , 13250-13253
Abstract
Most of the known senolytics are anti-cancer drugs or their derivative molecules. However, senolytics derived from the active ingredients of traditional Chinese medicine (TCM) are rarely reported. Here, we identified oridonin as a novel senolytic and further revealed that it might target a class of glutathione S-transferases to activate ROS-p38 signaling and induce apoptosis in senescent cells.Keywords
Funding Information
- National Key Research and Development Program of China (2020YFA0908000)
- State Administration of Traditional Chinese Medicine of the People's Republic of China (ZYYCXTD-C- 202002)
- National Science and Technology Infrastructure Program (2020YFE0205100)
- China Academy of Chinese Medical Sciences (CI2021A05101, CI2021A05104)
- Fundamental Research Funds for the Central Universities (ZZ15-YQ-062)
- National Natural Science Foundation of China (82074098, 81841001, 82274182)
This publication has 22 references indexed in Scilit:
- Identification of a novel senolytic agent, navitoclax, targeting the Bcl‐2 family of anti‐apoptotic factorsAging Cell, 2016
- Naturally occurring p16Ink4a-positive cells shorten healthy lifespanNature, 2016
- Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in miceNature Medicine, 2015
- The Achilles’ heel of senescent cells: from transcriptome to senolytic drugsAging Cell, 2015
- The role of senescent cells in ageingNature, 2014
- The Hallmarks of AgingCell, 2013
- Clearance of p16Ink4a-positive senescent cells delays ageing-associated disordersNature, 2011
- The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor SuppressionAnnual Review of Pathology: Mechanisms of Disease, 2010
- GLUTATHIONE TRANSFERASESAnnual Review of Pharmacology and Toxicology, 2005
- Comparison of early passage, senescent and hTERT immortalized endothelial cellsExperimental Cell Research, 2005